University of Chicago
Chicago, IL
- Fellowship, Nephrology
1986
Loyola University
Maywood, IL
- Residency, Internal Medicine
1982
University of Illinois
Chicago, IL
MD
1979
Augustana College
Rock Island, IL
BS - Biology
1974
Contrasting Response of Urine Stone Risk to Medical Treatment in Calcium Oxalate versus Calcium Phosphate Stone Formers.
Contrasting Response of Urine Stone Risk to Medical Treatment in Calcium Oxalate versus Calcium Phosphate Stone Formers. Kidney360. 2024 Feb 01; 5(2):228-236.
PMID: 38251931
Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls.
Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls. Am J Physiol Renal Physiol. 2023 12 01; 325(6):F811-F816.
PMID: 37823200
Metabolomic profiles and pathogenesis of nephrolithiasis.
Metabolomic profiles and pathogenesis of nephrolithiasis. Curr Opin Nephrol Hypertens. 2023 09 01; 32(5):490-495.
PMID: 37530089
A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease.
A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. Nat Commun. 2023 07 19; 14(1):4140.
PMID: 37468493
End Point Considerations for Clinical Trials in Enteric Hyperoxaluria.
End Point Considerations for Clinical Trials in Enteric Hyperoxaluria. Clin J Am Soc Nephrol. 2023 12 01; 18(12):1637-1644.
PMID: 37342976
Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers.
Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers. Clin J Am Soc Nephrol. 2023 08 01; 18(8):1059-1067.
PMID: 37256909
Clinical Effectiveness of Calcium Oxalate Stone Treatments.
Clinical Effectiveness of Calcium Oxalate Stone Treatments. Am J Nephrol. 2022; 53(10):761-766.
PMID: 36412567
What treatments reduce kidney stone risk in patients with bowel disease?
What treatments reduce kidney stone risk in patients with bowel disease? Urolithiasis. 2022 Oct; 50(5):557-565.
PMID: 35976425
Vitamin D and Parathyroid Hormone Levels in CKD.
Vitamin D and Parathyroid Hormone Levels in CKD. Am J Kidney Dis. 2023 01; 81(1):122-124.
PMID: 35926776
Stone Morphology Distinguishes Two Pathways of Idiopathic Calcium Oxalate Stone Pathogenesis.
Stone Morphology Distinguishes Two Pathways of Idiopathic Calcium Oxalate Stone Pathogenesis. J Endourol. 2022 05; 36(5):694-702.
PMID: 34915736